Royalty Pharma Total Liabilities and Share Holders Equity 2019-2024 | RPRX

Royalty Pharma total liabilities and share holders equity for the quarter ending September 30, 2024 was $18.042B, a 13.79% increase year-over-year.

  • Royalty Pharma total liabilities and share holders equity for 2023 was $16.382B, a 2.57% decline from 2022.
  • Royalty Pharma total liabilities and share holders equity for 2022 was $16.813B, a 4.01% decline from 2021.
  • Royalty Pharma total liabilities and share holders equity for 2021 was $17.516B, a 9.34% increase from 2020.

Royalty Pharma Total Liabilities and Share Holders Equity 2019-2024 | RPRX

  • Royalty Pharma total liabilities and share holders equity for 2023 was $16.382B, a 2.57% decline from 2022.
  • Royalty Pharma total liabilities and share holders equity for 2022 was $16.813B, a 4.01% decline from 2021.
  • Royalty Pharma total liabilities and share holders equity for 2021 was $17.516B, a 9.34% increase from 2020.